Skip to main content
. 2024 Jun 8;10(12):e32744. doi: 10.1016/j.heliyon.2024.e32744

Fig. 6.

Fig. 6

Development of the chemotherapeutic drugs and verification of Pan-cancer performance. (A) Distribution of the estimated IC50 of 5-Fluorouracil and Cisplatin among the high and low-risk groups in patients with colorectal cancer. (B) Kaplan–Meier curves of OS among 26 pan cancer species. (C) The forest map shows the effect of risk score on prognosis in 26 pan cancer species.